Organizations

Centre for the Commercialization of Regenerative Medicine

Centre for the Commercialization of Regenerative Medicine has met with MPs 7 times since January 2024, reaching 5 MPs in 1 party. Most recent contact: March 5, 2026.

7 meetings since 20248 all-time5 MPs1 parties0% by in-house staff

What they're asking for

In the registry's own words. Descriptions are only filed for meetings since mid-2024.

  1. Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.

    March 5, 2026 · John-Paul Danko · Liberal · Employment and Training; Health; Regional Development; Science and Technology; Research and Development

  2. Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility. The support will result in lower cost of life saving cell and gene therapy products.

    March 22, 2025 · Anita Anand · Liberal · Employment and Training; Health; Regional Development; Science and Technology; Research and Development

Full meeting log

7 MP-directed communications since January 2024, from the Registry of Lobbyists.

DateMP
2026-03-05John-Paul Danko · Liberal
2025-09-04Karim Bardeesy · Liberal
2025-09-03Karina Gould · Liberal
2025-03-22Anita Anand · Liberal
2025-03-20Karina Gould · Liberal
2024-06-06François-Philippe Champagne · Liberal
2024-06-03Karina Gould · Liberal
Counts include only communications where a sitting MP is the named public office holder — meetings with ministers' staff, senators, or departments are not shown. Registrants self-report these records. See our methodology.